TLR7 and dermatitis: When topically applied as a cream, imiquimod, a TLR7/8-stimulating compound, induces dermatitis that closely mimics psoriasis with typical hallmarks such as erythema, skin thickening, scaling, and epidermal alterations such as acanthosis and parakeratosis [38].